Rise and shine, everyone, another busy day is on the way. And this will be an especially busy one for us as we engage in a round of chats with a multitude of interesting folks. A break from the usual routine, in some ways. Nonetheless, we continue to forage for interesting items, despite the oppressive heat. So time to stay cool with another hot cup of stimulation, yes? As always, please feel free to join us. Meanwhile, here is a new batch of tidbits to help you along. Hope all goes well today and do stay in touch. …

“Little to no progress” has been made in achieving gender representation in the pharmaceutical industry, Pharmafile writes, citing a new report. Female representation on executive committees tripled to 26%, up from 8% in 2018, but representation in roles with profit and loss responsibility had halved over the same period to 4%, and representation of female executive directors on boards fell to 6% from 10%. Given these rates of change, the report estimated that it would take until 2090 before gender parity was reached in the industry.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy